Three details:
- The U.S. Army Medical Research and Development Command gave Oculogica a $2 million grant to develop a wearable device to assess mild traumatic brain injuries in soldiers. Children’s Hospital of Philadelphia, The University of Wisconsin-Green Bay and West Point, N.Y.-based Keller Army Hospital are partnering with Oculogica on developing the device.
- The project will begin either late this year or early in 2022. The device has the opportunity to aid in diagnosing concussions and monitoring recovery for the military and in sports medicine settings to identify individuals who may have concussions and aid in making decisions on when it’s appropriate to return to duty or sports.
- Christina Master, MD, physician and researcher at Children’s Hospital of Philadelphia and the co-director of the Minds Matter Concussion Program, said, “This is an advancement the field has been waiting for, and it is so needed. … The ability to take this to deployed settings, such as the military or sports field, is a critical next step.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
